105 / 119
104
Diretrizes AMB
psoriasis: a randomized trial. Lancet. 2001 Jun 9;357(9271):1842-7.
PubMed PMID: 11410193.
18. Reich K, Signorovitch J, Ramakrishnan K, Yu AP, Wu EQ, Gupta SR, Bao
Y, Mulani PM. Benefit-risk analysis of adalimumab versus methotrexate
and placebo in the treatment of moderate to severe psoriasis: comparison
of adverse event-free response days in the CHAMPION trial. J Am Acad
Dermatol. 2010 Dec;63(6):1011-8. PubMed PMID: 20933301.
19. Saurat JH, Stingl G, Dubertret L, Papp K, Langley RG, Ortonne JP,
Unnebrink K, Kaul M, Camez A; CHAMPION Study Investigators.